Abstract: A wearable computing device for identifying gestures indicating patient prescription adherence is provided. The wearable computing device includes a processor, a memory, and a motion sensor. The processor is configured to receive a set of prescription plan data defining a prescription for a pharmaceutical associated with a user of the wearable computing device. The processor is also configured to receive a gesture pattern of movement of the wearable computing device. The gesture pattern indicates that a patient is adhering to the prescription. The processor is further configured to detect, with the motion sensor, a first motion pattern associated with the wearable computing device. The processor is also configured to analyze the first motion pattern to determine if the gesture pattern has been performed. Upon determining that the gesture pattern has been performed, the processor is configured to update a prescription usage record.

Abstract: A wearable computing device for identifying gestures indicating patient prescription adherence is provided. The wearable computing device includes a processor, a memory, and a motion sensor. The processor is configured to receive a set of prescription plan data defining a prescription for a pharmaceutical associated with a user of the wearable computing device. The processor is also configured to receive a gesture pattern of movement of the wearable computing device. The gesture pattern indicates that a patient is adhering to the prescription. The processor is further configured to detect, with the motion sensor, a first motion pattern associated with the wearable computing device. The processor is also configured to analyze the first motion pattern to determine if the gesture pattern has been performed. Upon determining that the gesture pattern has been performed, the processor is configured to update a prescription usage record.

Abstract: The present invention provides a method of treating ovarian cancer in a mammal in need of such treatment comprising administering an effective amount of a combination of gemcitabine, cisplatin or carboplatin, and 5-[2-tert-butyl-5-(4-fluoro-phenyl)-1H-imidazol-4-yl]-3-(2,2-dimethyl-propyl)-3H-imidazo[4,5-b]pyridin-2-ylamine.

Abstract: The present invention provides a method of treating ovarian cancer in a mammal in need of such treatment comprising administering an effective amount of a combination of gemcitabine, cisplatin or carboplatin, and 5-[2-tert-butyl-5-(4-fluoro-phenyl)-1H-imidazol-4-yl]-3-(2,2-dimethyl-propyl)-3H-imidazo[4,5-b]pyridin-2-ylamine.

Abstract: A mobile communication device includes executable instructions for carrying out a method including setting a time duration for an application, receiving a first input, receiving a second input, determining the elapsed time between the first and second inputs, modifying the time duration based upon the elapsed time, and dimming a screen of the mobile device when the elapsed time exceeds the time duration.

Abstract: A mobile communication device includes executable instructions for carrying out a method including setting a time duration for an application, receiving a first input, receiving a second input, determining the elapsed time between the first and second inputs, modifying the time duration based upon the elapsed time, and dimming a screen of the mobile device when the elapsed time exceeds the time duration.

Abstract: A mobile communication device includes executable instructions for carrying out a method including setting a time duration for an application, receiving a first input, receiving a second input, determining the elapsed time between the first and second inputs, modifying the time duration based upon the elapsed time, and dimming a screen of the mobile device when the elapsed time exceeds the time duration.

Abstract: A mobile communication device includes executable instructions for carrying out a method including setting a time duration for an application, receiving a first input, receiving a second input, determining the elapsed time between the first and second inputs, modifying the time duration based upon the elapsed time, and dimming a screen of the mobile device when the elapsed time exceeds the time duration.

Abstract: A mobile communication device includes executable instructions for carrying out a method including setting a time duration for an application, receiving a first input, receiving a second input, determining the elapsed time between the first and second inputs, modifying the time duration based upon the elapsed time, and dimming a screen of the mobile device when the elapsed time exceeds the time duration.

Abstract: A mobile communication device includes executable instructions for carrying out a method including setting a time duration for an application, receiving a first input, receiving a second input, determining the elapsed time between the first and second inputs, modifying the time duration based upon the elapsed time, and dimming a screen of the mobile device when the elapsed time exceeds the time duration.